Alpha Tau Medical Ltd. (NASDAQ:DRTSW) Short Interest Update

Alpha Tau Medical Ltd. (NASDAQ:DRTSW) was the recipient of a significant decline in short interest in the month of June. As of June 15th, there was short interest totaling 2,774 shares, a decline of 82.5% from the May 31st total of 15,871 shares. Based on an average daily volume of 38,408 shares, the days-to-cover ratio is presently 0.1 days.

Alpha Tau Medical Stock Performance

Shares of DRTSW stock traded down $0.19 during midday trading on Friday, hitting $2.10. 60,101 shares of the company were exchanged, compared to its average volume of 57,264. The firm’s 50 day moving average price is $1.83 and its two-hundred day moving average price is $1.18. Alpha Tau Medical has a 52 week low of $0.20 and a 52 week high of $2.99.

About Alpha Tau Medical

Alpha Tau Medical Ltd. is a clinical-stage medical technology company focused on the development of alpha-emitting radiation therapy for the treatment of solid tumor cancers. The company’s proprietary Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) platform leverages the short-range, high-energy alpha particles emitted by radium-224 to penetrate tumor tissues more effectively than conventional external-beam radiation. By implanting thin, needle-like sources directly into a tumor, Alpha DaRT delivers concentrated doses of radiation to malignant cells while sparing surrounding healthy tissue.

The Alpha DaRT technology is designed to enhance local tumor control in a variety of solid tumors, including head and neck, breast, skin, and pancreatic cancers.